8-K//Current report
Viracta Therapeutics, Inc. 8-K
Accession 0000950170-25-008889
$VIRXCIK 0001061027operating
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 5:14 PM ET
Size
287.1 KB
Accession
0000950170-25-008889
Documents
- 8-Kvirx-20250123.htmPrimary
8-K
- EX-10.1virx-ex10_1.htm
EX-10.1
- EX-101.SCHvirx-20250123.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-008889-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLvirx-20250123_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Viracta Therapeutics, Inc.
CIK 0001061027
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001061027
Filing Metadata
- Form type
- 8-K
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 5:14 PM ET
- Size
- 287.1 KB